These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33469646)

  • 1. Proof of the triple prerequisite conditions which are essential for carbapenem resistance development in Klebsiella pneumoniae by using radiation-mediated mutagenesis.
    Pinto NA; D'Souza R; Nguyen LP; Vu TN; Yong D
    FEMS Microbiol Lett; 2021 Jan; 368(1):. PubMed ID: 33469646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of association of OmpK35 and OmpK36 alteration and bla
    Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
    Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem Resistance Caused by High-Level Expression of OXA-663 β-Lactamase in an OmpK36-Deficient Klebsiella pneumoniae Clinical Isolate.
    Ma P; Laibinis HH; Ernst CM; Hung DT
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.
    García-Sureda L; Doménech-Sánchez A; Barbier M; Juan C; Gascó J; Albertí S
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4742-7. PubMed ID: 21807980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
    Shi W; Li K; Ji Y; Jiang Q; Wang Y; Shi M; Mi Z
    Braz J Microbiol; 2013; 44(2):435-42. PubMed ID: 24294234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.
    Gröbner S; Linke D; Schütz W; Fladerer C; Madlung J; Autenrieth IB; Witte W; Pfeifer Y
    J Med Microbiol; 2009 Jul; 58(Pt 7):912-922. PubMed ID: 19502377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.
    Landman D; Bratu S; Quale J
    J Med Microbiol; 2009 Oct; 58(Pt 10):1303-1308. PubMed ID: 19556371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Susceptibility to Carbapenems in a Klebsiella pneumoniae Clinical Isolate Producing SCO-1 and CTX-M-15 β-Lactamases Together with OmpK35 and OmpK36 Porin Deficiency.
    Venditti C; Butera O; Proia A; Rigacci L; Mariani B; Parisi G; Messina F; Capone A; Nisii C; Di Caro A
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423955
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
    Joshi P; Shrivastava R; Bhagwat S; Patel M
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115481. PubMed ID: 34332307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Genetic Background of KPC-2-Producing
    Wu LT; Guo MK; Ke SC; Lin YP; Pang YC; Nguyen HV; Chen CM
    Microb Drug Resist; 2020 Sep; 26(9):1050-1057. PubMed ID: 32283046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
    Hamzaoui Z; Ocampo-Sosa A; Maamar E; Fernandez Martinez M; Ferjani S; Hammami S; Harbaoui S; Genel N; Arlet G; Saidani M; Slim A; Boutiba-Ben Boubaker I; Martinez-Martinez L
    Microb Drug Resist; 2018 Oct; 24(8):1137-1147. PubMed ID: 29373087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
    Kim SY; Shin J; Shin SY; Ko KS
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
    Bialek-Davenet S; Mayer N; Vergalli J; Duprilot M; Brisse S; Pagès JM; Nicolas-Chanoine MH
    Sci Rep; 2017 Jul; 7(1):6722. PubMed ID: 28751669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
    J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae.
    Zhang Y; Jiang X; Wang Y; Li G; Tian Y; Liu H; Ai F; Ma Y; Wang B; Ruan F; Rajakumar K
    Antimicrob Agents Chemother; 2014; 58(2):1214-7. PubMed ID: 24277031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.
    Chudácková E; Bergerová T; Fajfrlík K; Cervená D; Urbásková P; Empel J; Gniadkowski M; Hrabák J
    FEMS Microbiol Lett; 2010 Aug; 309(1):62-70. PubMed ID: 20528936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
    Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
    J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.
    Adler A; Ben-Dalak M; Chmelnitsky I; Carmeli Y
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5014-7. PubMed ID: 25987630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.